{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:28:02Z","timestamp":1790962082600,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01HL122200"],"award-info":[{"award-number":["R01HL122200"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21AG058445"],"award-info":[{"award-number":["R21AG058445"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K24HL148521"],"award-info":[{"award-number":["K24HL148521"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16EIA26410001"],"award-info":[{"award-number":["16EIA26410001"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.amjmed.2020.03.038","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T18:21:38Z","timestamp":1587320498000},"page":"e554-e567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2029-9754","authenticated-orcid":false,"given":"J'Neka S.","family":"Claxton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna M.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-1340","authenticated-orcid":false,"given":"Pamela L.","family":"Lutsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"MacLehose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay G.S.","family":"Bengtson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.amjmed.2020.03.038_bib0001","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjmed.2020.03.038_bib0002","first-page":"195","article-title":"Atrial fibrillation: the current epidemic","volume":"14","author":"Morillo","year":"2017","journal-title":"J Geriatr Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.038_bib0003","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"18","key":"10.1016\/j.amjmed.2020.03.038_bib0004","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.amjmed.2020.03.038_bib0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4070\/kcj.2018.0261","article-title":"Anticoagulation for stroke prevention in older adults with atrial fibrillation and comorbidity: current evidence and treatment challenges","volume":"48","author":"Sabbag","year":"2018","journal-title":"Korean Circ J"},{"key":"10.1016\/j.amjmed.2020.03.038_bib0006","doi-asserted-by":"crossref","first-page":"28","DOI":"10.15256\/joc.2011.1.4","article-title":"Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium","volume":"1","author":"Nobili","year":"2011","journal-title":"J Comorb"},{"key":"10.1016\/j.amjmed.2020.03.038_bib0007","unstructured":"Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States. 2014. Available at:https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2014\/demo\/p25-1140.pdf. Accessed April 19, 2019."},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.038_bib0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cger.2016.01.008","article-title":"Future research directions for multimorbidity involving cardiovascular diseases","volume":"32","author":"Salive","year":"2016","journal-title":"Clin Geriatr Med"},{"issue":"23","key":"10.1016\/j.amjmed.2020.03.038_bib0009","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2012.5265","article-title":"Designing health care for the most common chronic condition-multimorbidity","volume":"307","author":"Tinetti","year":"2012","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.amjmed.2020.03.038_bib0010","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.mayocp.2014.07.010","article-title":"Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race\/ethnicity","volume":"89","author":"Rocca","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjmed.2020.03.038_bib0011","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ahj.2016.11.008","article-title":"Multimorbidity and the risk of hospitalization and death in atrial fibrillation: a population-based study","volume":"185","author":"Chamberlain","year":"2017","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.038_bib0012","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1753944712464101","article-title":"Burden of comorbidities among patients with atrial fibrillation","volume":"7","author":"LaMori","year":"2013","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.038_bib0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cger.2016.01.013","article-title":"Epidemiology of multimorbidity in older adults with cardiovascular disease","volume":"32","author":"Bell","year":"2016","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.amjmed.2020.03.038_bib0014","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.amjmed.2020.03.038_bib0015","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.038_bib0016","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.amjmed.2020.03.038_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203599","article-title":"A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants","volume":"13","author":"Claxton","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.amjmed.2020.03.038_bib0018","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/eurjhf\/hft041","article-title":"Risk assessment for incident heart failure in individuals with atrial fibrillation","volume":"15","author":"Schnabel","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjmed.2020.03.038_bib0019","unstructured":"IBM Watson Health. IBM MarketScan Research Databases for Health Services Researchers (White Paper). Available at:https:\/\/www.ibm.com\/downloads\/cas\/6KNYVVQ2. Accessed February 25, 2020."},{"key":"10.1016\/j.amjmed.2020.03.038_bib0020","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.5888\/pcd10.120239","article-title":"Defining and measuring chronic conditions: imperatives for research, policy, program, and practice","volume":"10","author":"Goodman","year":"2013","journal-title":"Prev Chronic Dis"},{"issue":"9","key":"10.1016\/j.amjmed.2020.03.038_bib0021","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/pds.3674","article-title":"Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations","volume":"23","author":"Kim","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.amjmed.2020.03.038_bib0022","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/pds.2041","article-title":"Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data","volume":"20","author":"Garg","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.amjmed.2020.03.038_bib0023","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3122\/jabfm.2018.04.180008","article-title":"Multimorbidity trends in United States adults, 1988-2014","volume":"31","author":"King","year":"2018","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"10.1016\/j.amjmed.2020.03.038_bib0024","doi-asserted-by":"crossref","DOI":"10.5600\/mmrr.003.03.b02","article-title":"Multiple chronic conditions among Medicare beneficiaries: state-level variations in prevalence, utilization, and cost, 2011","volume":"3","author":"Lochner","year":"2013","journal-title":"Medicare Medicaid Res Rev"},{"issue":"5","key":"10.1016\/j.amjmed.2020.03.038_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11886-018-0975-x","article-title":"Addressing multimorbidity and polypharmacy in individuals with atrial fibrillation","volume":"20","author":"Shaikh","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"10.1016\/j.amjmed.2020.03.038_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001006","article-title":"Impact of atrial fibrillation on healthcare utilization in the community: the Atherosclerosis Risk in Communities study","volume":"3","author":"Bengtson","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.amjmed.2020.03.038_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2014.02.003","article-title":"Drivers of hospitalization for patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"167","author":"Steinberg","year":"2014","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.amjmed.2020.03.038_bib0028","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.amjmed.2020.03.038_bib0029","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.038_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.hrthm.2018.08.016","article-title":"Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: experience from the real world","volume":"16","author":"Alnsasra","year":"2019","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.038_bib0031","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.117.031658","article-title":"Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study","volume":"138","author":"Chao","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.amjmed.2020.03.038_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005657","article-title":"Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation)","volume":"6","author":"Patti","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.038_bib0033","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cger.2016.01.001","article-title":"Multimorbidity in older adults with atrial fibrillation","volume":"32","author":"Chen","year":"2016","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.amjmed.2020.03.038_bib0034","first-page":"555","article-title":"Managing atrial fibrillation in the very elderly patient: challenges and solutions","volume":"11","author":"Karamichalakis","year":"2015","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.038_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/hrt.2006.099903","article-title":"Rate control in the medical management of atrial fibrillation","volume":"93","author":"Camm","year":"2007","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.038_bib0036","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacep.2015.11.001","article-title":"Rhythm control versus rate control and clinical outcomes in patients with atrial fibrillation: results from the ORBIT-AF registry","volume":"2","author":"Noheria","year":"2016","journal-title":"JACC Clin Electrophysiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320303442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320303442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:22:12Z","timestamp":1757582532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934320303442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0002934320303442"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.03.038","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}